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Telomere capping is the essential function of
telomeres.To identifynewgenes involved in telo-
mere capping, we carried out a genome-wide
screen in Saccharomyces cerevisiae for sup-
pressors of cdc13-1, an allele of the telomere-
capping protein Cdc13. We report the identi-
fication of five novel suppressors, including the
previously uncharacterized gene YML036W,
which we name CGI121. Cgi121 is part of a
conserved protein complex—the KEOPS com-
plex—containing the protein kinase Bud32,
the putative peptidase Kae1, and the uncharac-
terized protein Gon7. Deletion of CGI121 sup-
presses cdc13-1 via the dramatic reduction
in ssDNA levels that accumulate in cdc13-1
cgi121 mutants. Deletion of BUD32 or other
KEOPS components leads to short telomeres
and a failure to add telomeres de novo to DNA
double-strand breaks. Our results therefore in-
dicate that the KEOPS complex promotes both
telomere uncapping and telomere elongation.
INTRODUCTION
The ends of eukaryotic chromosomes are protected from
degradation by a nucleoproteic structure called the telo-
mere (d’Adda di Fagagna et al., 2004; Lydall, 2003). In ad-Cdition to its essential cellular function in chromosome-end
protection, the telomere organizes chromosome-end rep-
lication in part by regulating the recruitment of telomerase,
an enzyme minimally consisting of an RNA component
and a reverse-transcriptase enzyme (Taggart and Zakian,
2003). Telomerase catalyzes the addition of tandem G-rich
repeats at the 30 end of linear chromosomes—TTAGGG
in vertebrates and TG1–3 in the budding yeast Saccharo-
myces cerevisiae.
In yeast, telomerase recruitment is mediated by the
Cdc13-Ten1-Stn1 complex and the Yku70/80 hetero-
dimer, both of which help to recruit telomerase via direct
physical interactions with its components (Pennock et al.,
2001; Stellwagen et al., 2003). Cdc13 is an OB fold-
containing protein that directly binds TG-rich telomeric
single-stranded (ss) DNA (Lin and Zakian, 1996; Nugent
et al., 1996). Thus, a critical step in Cdc13 and subsequent
telomerase recruitment involves the generation of an
ssDNA 30 overhang at chromosome ends. A number of
studies have underscored the role of the Mre11-Rad50-
Xrs2 (MRX) complex as a critical regulator of 30 overhang
generation and of Cdc13 recruitment (Diede and Gottsch-
ling, 2001; Larrivee et al., 2004).
Cdc13 and Yku70/Yku80 also play a critical role in chro-
mosome end protection (Cervantes and Lundblad, 2002).
Cells expressing mutant forms of the Cdc13 complex or
harboring deletions of YKU70/80 cannot adequately pro-
tect the telomeric CA-rich strand from nucleolytic degra-
dation (Garvik et al., 1995; Maringele and Lydall, 2002).
The telomere-capping function of these proteins is sepa-
rable from their telomere-elongation function but the factell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1155
that these two activities are derived from a single polypep-
tide suggests that both actions may be tightly coordinated.
At restrictive temperatures, strains carrying capping-
defective alleles of these genes generate large amounts
of ssDNA at telomeres and initiate a robust DNA-damage
checkpoint response that is dependent on MEC1 and
RAD9 (Garvik et al., 1995; Maringele and Lydall, 2002).
In addition to inducing checkpoint arrest and ensuing rep-
licative senescence (in human cells; d’Adda di Fagagna
et al., 2003) defects in telomere capping are a potent
threat to genome stability (DuBois et al., 2002; Hackett
et al., 2001).
Deletion either of genes encoding DNA-damage check-
point components (RAD9, MEC1, RAD24) or the gene
encoding the 50-30 exonuclease Exo1 suppress the check-
point arrest imparted by telomere-capping defects (Lydall,
2003). Checkpoint deficiency allows for continuous cell di-
vision despite the accumulation of ssDNA at uncapped
chromosome ends (Garvik et al., 1995; Maringele and
Lydall, 2002), whereas deletion of EXO1 curtails the gener-
ation of ssDNA, thus guarding against the formation of
a signal for checkpoint activation (Bertuch and Lundblad,
2004; Hackett and Greider, 2003; Maringele and Lydall,
2002; Zubko et al., 2004). Telomere-capping defects as-
sociated with the cdc13-1 allele can also be partially sup-
pressed by overexpression of the Stn1 protein, which
interacts directly with Cdc13 (Grandin et al., 1997). This
effect was also recently observed in strains with an abro-
gated nonsense-mediated pathway of mRNA decay (NMD
pathway). In NMD-deficient strains, the increased stability
of STN1 transcripts results in a corresponding increase in
Stn1 protein levels which, in turn, is able to suppress the
capping defect of cdc13-1 (Enomoto et al., 2004). Intrigu-
ingly, NMD and telomere metabolism may be more inti-
mately associated than previously thought, as the meta-
zoan homolog of the telomerase subunit Est1 appears to
play a dual role in NMD and telomere regulation (Chiu
et al., 2003; Reichenbach et al., 2003; Snow et al., 2003).
The exact nature of what constitutes a capped telo-
mere, the events that initiate progressive DNA resection
as a consequence of telomere dysfunction, and how telo-
mere capping may affect telomere elongation remain
largely unknown. In this study, we sought to identify novel
regulators of telomere structure in budding yeast using
a genome-wide functional genomics screen to isolate ge-
netic suppressors of the thermosensitive cdc13-1 allele.
We report the isolation of five suppressors of cdc13-1
and the detailed characterization of one of these, the
CGI121 (YML036W) gene. We show that Cgi121 functions
in a genetic pathway with and interacts physically with an
atypical and evolutionarily conserved protein kinase,
Bud32 within the KEOPS complex (for kinase, putative en-
dopeptidase and other proteins of small size). The KEOPS
complex acts as a critical regulator of telomere elonga-
tion at native telomeres and at DSBs as well as to pro-
mote telomere uncapping in cdc13-1 strains. This dual
role of the KEOPS complex appears unique among telo-
meric proteins and suggests that this conserved protein1156 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.kinase-containing complex links the processes of telo-
mere protection with telomere elongation.
RESULTS
To identify novel regulators of telomere metabolism or of
the checkpoint response to dysfunctional telomeres, we
employed synthetic genetic array (SGA) technology to in-
troduce the cdc13-1 mutation into a set of 4800 nones-
sential gene-deletion strains constructed in the S288c
strain background (Tong et al., 2001; Figure 1A). These
double-mutant strains were subsequently screened to
identify those with the ability to grow at 27.5ºC, nearly
2ºC above the maximum permissive temperature for
cdc13-1 strains. Using this approach, we recovered 9 of
11 expected null suppressors from the checkpoint and
NMD pathways, indicating that the screen was successful
in identifying known cdc13-1 suppressors (see Table S1 in
the Supplemental Data available with this article online).
We have thus far confirmed five novel suppressors of
the cdc13-1 capping defect, as tested in serial dilutions
assays in the W303 genetic background: the pif1D,
ebs1D, bmh1D, san1D, and yml036D mutations (Fig-
ure 1B). PIF1 encodes a helicase that functions as a nega-
tive regulator of telomerase (Boule et al., 2005; Schulz and
Zakian, 1994). EBS1 codes for an Est1 paralog, and ebs1D
cells have a short-telomere phenotype, suggesting a role
in normal telomere metabolism (Zhou et al., 2000). BMH1
encodes a member of the 14-3-3 family of proteins that
are phosphoserine binding proteins involved in a number
of signaling processes, including checkpoint signaling
(Lottersberger et al., 2003). San1 encodes an E3 ubiquitin
ligase that functions to target misfolded nuclear proteins
for destruction, and its deletion stabilizes the Cdc13-1 pro-
tein (Gardner et al., 2005). Finally, YML036W encodes a
previously uncharacterized gene product of a predicted
molecular weight of 21.8 kDa with no recognizable do-
mains or motifs. YML036W is highly conserved in eukary-
otes, with the exception of Drosophila (Figure S1). The hu-
man homolog of YML036W is known as CGI-121 and was
identified in a two-hybrid screen using the putative p53
protein kinase PRPK as bait (Miyoshi et al., 2003). We
propose to give the name CGI121 to the YML036W ORF
to reflect this relationship.
Given its evolutionary conservation and its poorly
understood function, we focused our attention on the
role of CGI121 in telomere metabolism. To determine
whether cgi121D is able to suppress the telomere-
capping defects of a YKU deletion or of CDC13 alleles
other than cdc13-1, we introduced the cgi121D muta-
tion into cells carrying the yku70D mutation and the
temperature-sensitive ssDNA binding defective allele of
CDC13, cdc13-6 (Hughes et al., 2000). As shown in Fig-
ure 2A, cgi121D yku70D double mutants are able to
grow at 37ºC, whereas yku70D cells are inviable at this
temperature. Likewise, the cgi121D mutation results in
the suppression of cdc13-6 temperature sensitivity at
34ºC (Figure 2B). These observations demonstrate that
the cgi121D mutation does not solely suppress cdc13-1
and can suppress other temperature-sensitive defects
caused by loss of telomere capping.
The cgi121D Mutation Suppresses ssDNA
Accumulation in the cdc13-1 Strain
Deficiencies in checkpoint signaling and the NMD path-
way can both increase the cdc13-1 restrictive tempera-
ture. We therefore assessed whether Cgi121 is a compo-
nent of either of these pathways. To determine whether
the cgi121D mutation affects the checkpoint response to
dysfunctional telomeres, we introduced the cgi121D mu-
tation into cdc13-1 cdc15-2 strains (Lydall and Weinert,
1995). At 36ºC, cgi121D cdc13-1 cdc15-2 strains arrest
at metaphase within the first round of cellular division, as
would be expected for cells proficient in checkpoint sig-
Figure 1. A Screen for Null Suppressors of cdc13-1
(A) Schematic depiction of the screen. The DLY2304 strain containing
a cdc13-1 allele flanked by URA3 and LEU2 genes was mated to an
arrayed set of 4800 MATa haploid deletion mutants, each carrying a
different null mutation linked to the KANMXmarker. Following sporula-
tion, haploid cells were selected by using a MATa-specific promoter
driving transcription of the HIS3 gene. The resulting double-mutant
strains were then grown in liquid cultures and spotted on agar plates
to test their ability to grow at temperatures permissive or restrictive
for cdc13-1 growth.
(B) Five-fold serial dilutions of the indicated strains were spotted onto
rich media and grown for three days at the indicated temperatures.naling, despite a delay in progression through the cell cy-
cle (Figures 2C and 2D). In stark contrast, a rad9D cdc13-1
cdc15-2 strain fails to accumulate at metaphase and ar-
rests instead in telophase, at the cdc15-2 arrest point (Fig-
ures 2C and 2D). We therefore conclude thatCGI121 is not
directly involved in the checkpoint response to dysfunc-
tional telomeres.
Secondly, we tested whether Cgi121 was involved in
the NMD pathway by examining the levels of the NMD-
sensitive Stn1 protein (Enomoto et al., 2004) or by exam-
ining the abundance of the CYH2 pre-mRNA, a direct tar-
get of the NMD pathway (He et al., 1993). As shown in
Figure S2, two different cgi121D isolates fail to show the
dramatic increase in Stn1 or CYH2 pre-mRNA levels ob-
served in upf2D cells. In addition, upf2D cgi121D double
mutants are more potent suppressors of cdc13-1 tem-
perature sensitivity than either single mutant (data not
shown), suggesting that these genes are not epistatic
and function instead within different genetic pathways.
Hence, we conclude that Cgi121 is not directly involved
in the NMD pathway.
Thirdly, we sought to examine whether strains carrying
the cdc13-1 and cgi121D mutations accumulate RAD52-
dependent ‘‘survivors’’ showing the amplification of telo-
meric repeats characteristic of telomerase-deficient cells
(Chen et al., 2001; Lundblad and Blackburn, 1993). Such
telomeric recombination events can support the growth
of cdc13-1 cells at elevated temperatures (Grandin
et al., 2001). As shown in Figure S2C, cgi121D cdc13-1
strains do not show amplification of either Y- or TG-tract
repeats characteristic of survivors. In addition, deletion
of RAD52 does not affect the extent of cdc13-1 suppres-
sion by the cgi121D mutation (data not shown), indicating
that the suppression of cdc13-1 temperature sensitivity
cannot be explained by the accumulation of ‘‘survivors.’’
Lastly, we tested directly whether the cgi121Dmutation
reduced the amount of ssDNA detected in cdc13-1
mutants near telomeres. In cdc13-1 mutants, ssDNA is
generated in a telomere-to-centromere direction, with
Rad24 and Exo1 being required for ssDNA production
while Rad9 inhibits ssDNA production (Booth et al.,
2001; Zubko et al., 2004). As shown in Figures 2F–2H,
when asynchronously dividing cdc13-1 cultures are
shifted at restrictive temperature (28ºC), ssDNA accumu-
lates specifically on the 30 TG strand, but not the 50 AC
strand, at loci 600 bp or 8.5 kb away from the chromo-
some end. As expected, deletion of EXO1 in these strains
severely curtails the accumulation of ssDNA at both loci
and close to the background levels seen in the CDC13+
strain, at the 8.5 kb locus. Interestingly, we find that dele-
tion of CGI121 results in a similar inhibition of ssDNA
generation at both loci, indicating that the cgi121D is a
potent suppressor of ssDNA accumulation in cdc13-1mu-
tants at 28ºC. This suppression of ssDNA accumulation
correlates with the suppression of cdc13-1 thermosensi-
tivity and indicates that loss of Cgi121 from yeast cells
suppresses cdc13-1 thermosensitivity by limiting the
amount of ssDNA generated at uncapped telomeres.Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1157
Figure 2. Deletion of CGI121 Suppresses Telomere-Capping Defects
(A and B) Deletion of CGI121 suppresses the temperature-sensitive growth defects associated with the yku70D (A) and cdc13-6 (B) mutations. Serial
dilutions of strains DDY663 (yku70D) DDY664 (cgi121D), DDY665 (cgi121D yku70D), DDY595 (cdc13-6), DDY673 (cdc13-6 rad9D), and DDY676
(cdc13-6 cgi121D) were spotted on rich media and grown for 3–5 days at the indicated temperatures. We noted that the suppression of yku appears
specific to yku70D in S288C.
(C and D) CGI121 is not involved in the checkpoint response to uncapped telomeres. cgi121D cdc13-1 cdc15-2 (DDY582) strains accumulate at the
G2/M arrest point during the course of a single cell-cycle when cultured at 37ºC. Following release from G1 arrest, cells were stained with DAPI and
examined by microscopy to score for the presence of large dumbbell-shaped cells containing a single nucleus (C) or two nuclei (D), indicative of meta-
phase or telophase arrest, respectively.
(E–H) cgi121D cdc13-1 fail to accumulate ssDNA at telomeres.
(E) Loci used to measure single-strand DNA in cdc13-1 mutant cells.
(F and G) ssDNA measured on the ‘‘TG strand’’ at the indicated distances from the telomere following a shift of logarithmically growing cells from 23ºC
to the restrictive permissive temperature of 28ºC.
(H) Measurement of ssDNA accumulation on the AC strand under the same conditions.
Error bars indicate the standard error of the mean.1158 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.
Cgi121 Interacts and Functions with the Bud32
Protein Kinase
As described above, the human homolog of Cgi121, CG1-
121, interacts with the putative p53 Ser15 kinase PRPK
(Miyoshi et al., 2003). Based on sequence homology,
a clear PRPK ortholog can be identified in budding yeast,
the previously named Bud32 (Figure S1; Facchin et al.,
2003). Homozygous null mutants of BUD32 display a de-
fect in bipolar budding pattern (Ni and Snyder, 2001),
but the molecular basis for this defect is unknown. Bud32
is a nuclear protein and was found to interact with Cgi121
in a high-throughput protein-protein interaction study (Ho
et al., 2002), further supporting the notion that the
hCGI-121/PRPK interaction may be conserved in yeast.
To test this possibility, we coexpressed epitope-tagged
forms of Bud32 and Cgi121 and examined their ability to
interact in coimmunoprecipitation experiments. Epitope-
tagged Bud32 (or native Bud32; data not shown) associ-
ates with HA-tagged Cgi121 (Figure 3A). Thus, consistent
with the physical interaction of their human homologs,
Bud32 and Cgi121 form a stable protein complex.
Next, we determined if a bud32D mutation could also
suppress cdc13-1 temperature sensitivity. As shown in
Figure 3B, the bud32D mutation is a potent suppressor
of cdc13-1, being able to suppress cdc13-1 at tempera-
tures up to 30ºC–32ºC. This level of suppression is espe-
cially remarkable given the fact that bud32D strains have a
slow growth phenotype at these temperatures (Figure 3B;
Facchin et al., 2002). Since Bud32 is a protein kinase, we
next examined whether the kinase activity of Bud32 was
required for the apparent negative impact of Bud32 on
telomere capping. We thus generated the bud32-K52A
allele, which essentially abolishes the phosphotransferase
activity of Bud32 (Facchin et al., 2002) and introduced it
into cdc13-1 bud32D cells. As a control, the reintroduction
of wild-type BUD32 abolishes the ability of the bud32D
mutation to suppress cdc13-1 (Figure 3C). Thus, bud32D
suppression of cdc13-1 temperature sensitivity is not
due to a mutation unlinked to BUD32. In contrast, the
kinase-dead allele of BUD32 does not abrogate the sup-
pression of temperature sensitivity in cdc13-1 bud32D
cells but does, however, greatly improve the growth of
the bud32D strain. These results suggest that Bud32, like
Cgi121, promotes telomere uncapping in budding yeast
under conditions of telomere dysfunction and that the
catalytic activity of the Bud32 kinase is required for the ob-
served effect.
We found that both the ebs1D and pif1Dmutations sup-
press cdc13-1 (Figure 1). Since deletion of these genes
also alters telomere length, we measured average telo-
mere length in strains containing the bud32D, cgi121D,
or bud32D cgi121D mutations (Figure 3D). Strikingly,
bud32D cells have dramatically shortened telomeres rela-
tive to wild-type strains. The short-telomere phenotype of
bud32D strains is fully suppressed by reintroduction of
a wild-type copy of BUD32 (Figure 3E) indicating that the
defect of these strains is imparted by the loss of BUD32.
The maintenance of normal telomere length by Bud32also requires its kinase activity (Figure 3E) suggesting
that Bud32 may modulate the activity of one or more
telomere regulatory proteins via reversible protein phos-
phorylation.
In parallel with the observation that the cgi121D muta-
tion is a weaker suppressor of cdc13-1 than the bud32D
mutation, cgi121D cells also display shortened telomeres
but to a lesser degree than those seen in bud32D cells
(Figure 3D). Furthermore, BUD32 and CGI121 appear
to function in the same pathway of telomere-length main-
tenance, since deletion of both CGI121 and BUD32
does not result in any further decrease in telomere length
(Figure 3D).
Remarkably, telomeres in bud32D strains are as short
as those in tel1D or yku70D strains (Figure 4A). However,
BUD32 does not appear to participate in either the YKU
or TEL1-dependent pathways of telomere maintenance
as the bud32D yku70D and bud32D tel1D strains were
both shorter than the single mutants (Figure S3). We also
observe that telomeres in cgi121D yku70D and cgi121D
tel1D strains are shorter than either yku70D and tel1D
strains, respectively (data not shown). Likewise, BUD32
(or CGI121) does not act in the PIF1 or RIF1 pathways of
telomere elongation since telomere length in bud32D rif1D
or bud32D pif1D strains is at an intermediary length be-
tween those of bud32D and either pif1D or rif1D strains, re-
spectively (Figure S3). However, we note that the telomere
length of the pif1D bud32D strains are nearly that of
the bud32D strains, perhaps indicating some functional
overlap between those two genes. Finally, to determine
whether BUD32 functions within the telomerase-depen-
dent pathway of telomere maintenance we generated an
est2D/EST2 bud32D/BUD32 diploid strain. After sporula-
tion, the resulting congenic est2D, bud32D, and bud32D
est2D strains were serially passaged to analyze the rate
of cellular senescence. Deletion of genes functioning out-
side the telomerase pathway is expected to accelerate the
senescence of telomerase-negative strains (Nugent et al.,
1998). However, BUD32 deletion does not accelerate
the onset of senescence in est2D cells (Figure 4B), and
bud32D est2D telomeres shorten at a rate comparable to
est2D single mutants (Figure 4C). We therefore conclude
that Bud32 functions predominantly within the telome-
rase-mediated pathway of telomere-length maintenance.
Cgi121 and Bud32 Are Part of the Larger
KEOPS Complex
As part of an ongoing large-scale study of the yeast inter-
actome (N.J.K., A.E. and J.F.G., unpublished data), Bud32
and Cgi121 were found to be in a complex with Gon7
(Yjl184w) and Kae1 (Ykr038c) following tandem affinity pu-
rifications of Bud32-TAP, Gon7-TAP, and Kae1-TAP
(Figure 5A). Grx4 and Grx3, two related glutaredoxins,
were also found to associate with TAP-tagged Bud32
but not with Gon7-TAP or Kae1-TAP (Figure 5A), a result
also supported by yeast two-hybrid and Flag-epitope im-
munopurifications (Ho et al., 2002; Lopreiato et al., 2004).
This observation may indicate that Bud32 is part of twoCell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1159
Figure 3. Cgi121 Forms a Function Com-
plex with Bud32
(A) Bud32 and Cgi121 interact physically. Anti-
HA immunoprecipitations were carried out
in extracts prepared from strains DDY634,
DDY638, or DDY632 grown in the presence
of galactose. Bud32-FLAG and 3HA-Cgi121
were detected by mouse anti-FLAG M2 and
anti-HA (clone 12CA5) antibodies, respectively.
Ten percent of the whole-cell extract used
in the immunoprecipitation was loaded as
control.
(B) bud32D mutants are potent suppressors
of cdc13-1 temperature sensitivity. Five-fold
serial dilutions of the DDY1199 (cdc13-1
bud32D), DDY1200 (bud32D), DDY1201
(cdc13-1) strains were spotted on rich media,
and plates were incubated at the indicated
temperatures for 3 days (30ºC and 34ºC) or
5 days (25ºC).
(C) The role of Bud32 in telomere capping
is mediated by its kinase activity. Plasmid
DDp472 (pBUD32) or plasmid DDp473
(pbud32-K52A) were introduced in bud32D
cdc13-1 cells (DDY723), and the ability of these
strains to grow at temperatures restrictive for
cdc13-1 was evaluated.
(D) bud32D and cgi121D cells have short telo-
meres. Telomere length analysis of wild-type
(DDY662), cgi121D (DDY762), bud32D
(DDY763), and cgi121D bud32D (DDY765)
strains. Lanes 4–9 represent strains passaged
to single colonies six times after plasmid loss
on 5-FOA media from cgi121D pCGI121,
bud32D pBUD32, or stc1D bud32 pBUD32
strains.
(E) Kinase-dead Bud32 does not support nor-
mal telomere length. TRF analysis of average
telomere length in strains wild-type (S288c)
strains, bud32D (DDY1230), or bud32D strains
containing plasmid DDp472 (pBUD32) or plas-
mid DDp473 (pbud32-K52A).complexes: a first one where Bud32 is bound to glutare-
doxins and a second with Gon7, Cgi121, and Kae1. Gon7
is a small protein of unknown function, whereas Kae1 is
a putative endopeptidase. Further supporting that the
Kae1-Bud32 interaction has functional significance, some
archaeal genomes encode a fusion of bacterial Kae1 and
Bud32 homologs (Lopreiato et al., 2004). To confirm these
interactions, we immunoprecipitated TAP-tagged ver-
sions of Kae1, Gon7, or Grx4 and assayed for the pres-
ence of native Bud32 in the immunoprecipitates. As1160 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.shown in Figure 5B, Bud32 is detected in Gon7 and Kae1
immunoprecipitates. However, we could not detect Bud32
in Grx4-immunoprecipitates, in contrast to the prior stud-
ies of Lopreiato et al. (2004). A reason for this discrepancy
may be that we used a C-terminally tagged Grx4 that
might interfere with the Grx4-Bud32 interaction. Neverthe-
less, these results suggest that Bud32 forms a multiprotein
complex with Cgi121, Kae1, and Gon7. Indeed, using gel
filtration studies (Figure S4), we find that Kae1 and Bud32
coelute and have hydrodynamic properties consistent
with a multiprotein complex of approximately 400 kDa.
Based on these observations, we suggest the name
KEOPS to describe this complex (for kinase, putative en-
dopeptidase and other proteins of small size).
Consistent with Bud32 and Cgi121 carrying out their
functions as part of a larger complex containing Gon7
and Kae1, deletion of GON7 results in a large decrease in
telomere length (Figure 5C). Since KAE1 is essential, we
have not tested whether loss-of-function kae1 mutants
also result in telomere-length defects. Nevertheless, our
resultsareconsistentwith the KEOPScomplex,asawhole,
participating in the regulation of telomere metabolism.
BUD32 Is Essential for Telomere Healing
Telomere healing (also termed ectopic telomere addition)
is a type of gross chromosomal rearrangement that oc-
curs when telomerase acts on DSBs. Addition of a new
telomere to a DSB almost invariably results in the loss of
genetic information, and, in cells with haploid genomes,
this type of chromosomal aberration is only tolerated when
the telomere healing event occurs toward the end of a
chromosome, in regions devoid of essential genes. Impor-
tantly, the mechanisms leading to ectopic telomere addi-
tion differ from telomere length homeostasis at native
chromosome ends in one important regard: sequences
surrounding DSBs generally lack the long double-stranded
TG-repeat tracts bound by the Rap1/Rif1 proteins that are
involved in telomere-length homeostasis. Therefore, telo-
mere healing depends largely on the processing of the DNA
end and the ensuing stepwise recruitment of Cdc13, fol-
lowed by Est1 and associated telomerase components
(Bianchi et al., 2004; Diede and Gottschling, 1999; Diede
and Gottschling, 2001; Myung et al., 2001). To determine
if BUD32 is involved in telomere healing, we took advan-
tage of the GCR system developed by Kolodner et al.
which examines the spontaneous loss of URA3 and
CAN1 on Chr V-L (Figure 6A; Chen and Kolodner, 1999).
URA3 and CAN1 are markers that can be counterselected
on 5-fluroro-orotic acid (5-FOA) and canavinine (CAN), re-
spectively, and, in wild-type strains, these two markers
are lost simultaneously at a rate of 2  1010 (Chen and
Kolodner, 1999). In wild-type strains, cells that have under-
gone a GCR event, leading to loss of URA3 and CAN1, re-
pair their spontaneously broken chromosomes mainly via
nonreciprocal translocation and telomere healing, with
a clear bias toward telomere healing (Chen and Kolodner,
Figure 4. Telomere-Length Phenotypes in bud32D Cells
(A) TRF analysis reveals that telomeres in bud32D (DDY1230) cells are
as short or shorter than those of tel1D (DDY1232) or yku70D (DDY663)
cells.
(B) Deletion of bud32D does not increase the rate of cellular sen-
escence in est2D cells. A bud32D/BUD32 est2D/EST2 strain
(DDY1227) was sporulated, and spores of the indicated genotype
were passaged to single colonies on rich media. est2D and bud32D
est2D strains both failed to form single colonies after three passages.
(C) Telomere length in senescing strains. Telomeres in bud32D est2D
and est2D strains are eroded at a similar rate. Two sequential pas-
sages are shown.Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1161
Figure 5. Identification of the KEOPS Complex
(A) Identification of KEOPS components using mass spectrometry. Bud32-TAP, Gon7-TAP, or Kae1-TAP were purified by tandem affinity purification
(Rigaut et al., 1999), and associated proteins were purified using SDS-PAGE prior to identification using MALDI-TOF mass-spectrometry (bands
labeled by arrows on the left panel) or analyzed without gel purification by LC-MS (right panel; X denotes positive identification by LC-MS).
(B) Indicated TAP-tagged proteins were purified by immunoprecipitation and analyzed using SDS-PAGE, followed by Western analysis using an anti-
Bud32 antibody. Ten percent of the input was loaded as control.
(C) Telomere length in strains deleted for individual KEOPS components: bud32D (DDY1230), cgi121D (DDY664), grx4D (DDY1238), gon7D
(DDY1239).1999). Interestingly, by virtue of its role as a negative regu-
lator of telomerase, deletion of the gene encoding Pif1 al-
lows for a dramatically increased rate of recovery of GCR
events, with the great majority having undergone telomere
healing (Mangahas et al., 2001; Myung et al., 2001). We
therefore tested whetherBUD32was required for telomere
healing of DSBs in pif1DChrV CAN1-URA3 strains by per-
forming GCR assays. As controls, we also examined the
contribution of YKU70 and TEL1 to telomere healing in this
context (Myung et al., 2001). As expected, we observed
a dramatic reduction in the rate of GCR events observed
in pif1D strains carrying a deletion of YKU70, consistent
with its function in directly assisting with telomerase
recruitment (Figure 6B; Myung et al., 2001; Stellwagen
et al., 2003). Deletion of TEL1 had little effect on the GCR
rate of a pif1D strain, recapitulating the results of Myung1162 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.et al. (2001) and confirming the dependence of Tel1 action
on the presence of the Rap1/Rif proteins that bind to pre-
existing double-stranded TG repeats (Craven and Petes,
1999). Remarkably, BUD32 deletion dramatically sup-
pressed the mutation rate associated withpif1D -mediated
telomere healing to levels slightly lower than the yku70D
pif1D strain (Figure 6B). This result indicates that BUD32
has a role in ectopic telomere addition and suggests that
the function of Bud32 may not depend on a preexisting
telomere. Collectively, these results suggest that Bud32
may either regulate telomerase recruitment, telomerase
activity, or may act downstream of Pif1 in the regulation
of telomere elongation and healing events.
To further delineate the requirement for Bud32 during
telomere healing, independently of a pif1D deletion, we
turned to a system recently described by Bianchi et al.
Figure 6. Deletion of BUD32 Suppresses Gross Chromosomal Rearrangements Associated with Telomere Additions
(A) Schematic representation of the GCR assay. Cells losing CAN1 and URA3 but retaining viability following a GCR event are selected on media
containing the drugs 5-FOA and canavanine.
(B) BUD32 is required for the elevated GRC rates observed in pif1D cells.
(C) Schematic representation of the telomere-healing assay following a targeted double-strand break. Telomere-healing events are selected by plat-
ing of cells on a-aminoadipate plates following galactose induction of the HO-endonuclease. Presence of a Gal4 DNA binding domain (GBD) fused to
Est1 greatly stimulates telomere-healing efficiency.
(D) Targeting of an Est1-GBD fusion protein to DSB sites increases telomere healing in wild-type (DDY1217) but not bud32D cells (DDY1222). Cells
were grown in synthetic media lacking tryptophan and uracil but containing raffinose prior to addition of galactose. Cells were plated on rich media,
and telomere-healing events were selected by replica plating on a-aminoadipate plates lacking adenine.(2004) and schematized in Figure 6C. This system relies on
the galactose-inducible expression of the HO endonucle-
ase to create a DSB at a site near the end of chromosome
VII-L. Like the GCR assay described above, this system
monitors telomere-healing events via the loss of the
DSB-distal markers URA3 or LYS2 (counterselected by
5-FOA and a-aminoadipate, respectively). At a position
that is centromere proximal to the HO site are a series of
tandem Gal4 DNA binding sites (UASg), which allow for
the recruitment of proteins fused to the Gal4 DNA binding
domain (GBD). Expectedly and as previously reported, we
found that the percentage of cells undergoing telomere
healing events was greatly stimulated by the expression of
an Est1-GDB fusion protein, when compared with strains
that express the GDB protein alone (Figure 6D). By stark
contrast, a strain containing aBUD32 deletion is highly de-
ficient in its ability to add telomeres to a DSB even when anCEst1-GDB fusion is expressed (Figure 6D). These results
suggest that Bud32 is not involved in the series of events
that leads to Est1 recruitment, as its targeting by artificial
means does not rescue the profound telomere healing
defect of a bud32D strain.
BUD32 Is Required Downstream
of Telomerase Recruitment
The profound telomere-healing defect of bud32D strains
spurred us to test whether physical targeting of telome-
rase subunits to natural telomeres also requires Bud32
for efficient telomere elongation. We expressed in wild-
type or bud32D cells fusion proteins covalently linking
Est1, Est2, the catalytically inactive Est2D670A mutant,
and Est3 to Cdc13 (either full-length or its DNA binding do-
main; Evans and Lundblad, 1999; Pennock et al., 2001).
These fusion proteins are able to elongate telomeres byell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1163
short-circuiting telomerase recruitment at telomeres.
Accordingly, in wild-type cells, we observed that physi-
cally tethering Est1, Est2, or Est3 to telomeres results in
telomere lengthening ranging from 357 to 604 bp after 75
generations (Figures 7A and 7B) while tethering the cata-
lytically inactive Est2 mutant results in a slight telomere-
shortening phenotype (Figures 7A and 7B). In sharp con-
trast, the same fusion proteins expressed in bud32D cells
are severely defective in telomere elongation with length-
ening averaging 3–43 bp only, after over 100 generations
of growth (Figures 7A and 7B). These results suggest that
Bud32 is required downstream of telomerase recruitment
at chromosome ends.
The failure of Cdc13-Est fusion proteins to promote
telomere elongation in bud32D cells is somewhat reminis-
cent of the failure of Cdc13-Est2 to promote elongation in
est1D cells (Evans and Lundblad, 1999). In est1D cells ex-
pressing a Cdc13-Est2 fusion, telomeres do not elongate
nor progressively shorten to trigger senescence. This data
illuminated a poorly characterized activity of Est1 that may
either concern telomerase activation (Taggart et al., 2002)
or access to the 30 end of the chromosome (Evans and
Lundblad, 1999). We therefore sought to determine telo-
mere length in an est1D bud32D double-mutant strain
expressing the CDC13-EST2 fusion to assess whether
BUD32 acts in the same pathway as EST1. As shown in
Figure 7C, the telomeres of four generated bud32D
est1D <CDC13-EST2> strains, although more heteroge-
neous than in Figure 7A, are at lengths similar to those
observed in est1D <CDC13-EST2> cells. These results
suggest that BUD32 may act in or overlap with the EST1
pathway of telomere elongation at a step downstream of
telomerase recruitment.
One possible explanation for the profound effect of the
BUD32 deletion on telomere-length homeostasis and
telomere healing is that Bud32 is required for optimal tel-
omerase activity. To test this possibility, we fractionated
S100 extracts from wild-type, bud32D and est2D cells
on DEAE Sepharose as described in Cohn and Blackburn
(1995) and assayed for telomerase activity in these frac-
tions by primer-extension assays. As shown in Figures
7D and S6, extracts from bud32D cells show RNase-
sensitive telomerase activity that is almost identical to
that of wild-type cells under the conditions tested. These
results clearly indicate that Bud32 is not required for telo-
merase activity on synthetic primers, an activity that is
independent of the Est1 and Est3 subunits under the
conditions used. Collectively, these results are consistent
with a model whereby Bud32 may be required for an activ-
ity of telomerase that is independent of recruitment.
DISCUSSION
Functional Genomic Analysis of Telomere Capping
The nature of what constitutes a ‘‘protected’’ chromo-
some end or how chromosome end-structure functionally
impacts telomere length homeostasis is poorly under-
stood. This question is fundamental to the understanding1164 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.of how telomere erosion due to ageing is linked to genome
instability and the development of malignancies. Using
budding yeast, we have adapted synthetic genetic array
technology (Tong et al., 2001) to identify novel gene dele-
tions that increase the maximal permissive temperature of
cdc13-1, a model for the loss of telomere capping. From
this screen, we have identified six novel suppressors of
cdc13-1 (including bud32D). Most of these suppressors
suggest novel avenues of study related to telomere cap-
ping at the molecular level. For example, our finding that
the deletion of PIF1 increases some aspect of telomere
capping is intriguing given its proposed role as a negative
regulator of telomerase (Boule et al., 2005). If Pif1 affects
the capping of telomeres via its influence on telomerase,
our results would suggest that the telomerase-DNA inter-
action may somehow be involved in telomere capping, as
previously suggested by the finding that overexpression of
telomerase components suppress the temperature sensi-
tivity of cdc13-1 and ykuD mutants (Nugent et al., 1998;
Teo and Jackson, 2001). In addition, since Est1 proteins
appear to have a 14-3-3 fold (Fukuhara et al., 2005), our
finding that the deletion of EBS1 or BMH1 suppresses
cdc13-1 may suggest that phosphodependent protein-
protein interactions play an important role in the regulation
of telomere capping in eukaryotes.
In this study, we focused our efforts on the characteriza-
tion of the YML036W gene, which encodes a highly con-
served protein of small size and of unknown function.
We have given the name CGI121 to YML036W, to reflect
its orthologous relationship with human hCGI-121. Four
different assays were performed to assess the role of
Cgi121 (or its interacting protein Bud32) in telomere biol-
ogy: first, we found that Cgi121 and Bud32 appear to co-
operate with the cdc13-1 mutation to promote telomere
uncapping, as their deletion suppresses the temperature
sensitivity of cdc13-1 via the abrogation of ssDNA gener-
ation at telomeres. Second, cells lacking individual KEOPS
components (Gon7, Bud32, and Cgi121) display stable
telomere shortening, indicating that they play a positive
role in telomere elongation. Third, Bud32 is required for
de novo addition of telomeres at DSBs. Fourth, Bud32 is
required for the ability of telomere bound telomerase to
elongate telomeres. Collectively, all these observations
are consistent with a model whereby the KEOPS complex
is a critical and novel regulator of telomere metabolism in
eukaryotes.
A Model of KEOPS Complex Function at Telomeres
Any model attempting to explain the function of the
KEOPS complex at telomeres must account for the fact
that Bud32 and Cgi121 act both as positive regulators of
telomere elongation and as promoters of telomere uncap-
ping. The function of the KEOPS complex in telomere
capping is likely to be solely manifest during conditions
of telomere dysfunction as deletion of CGI121 does not
have on its own a major impact on telomere capping
as measured by a telomere-capture assay (Figure S5;
DuBois et al., 2002). Whether these two different aspects
Figure 7. Bud32 Is Required for Activity of Telomere Bound Telomerase
(A) Telomere-length analysis of wild-type (left panel) or bud32D cells (right panel) expressing Cdc13-Est1, Cdc13-Est2, Cdc13-Est2D670A, or
Cdc13DBD-Est3 fusion proteins or harboring a control vector (pRS415). Lanes 15 and 16 show telomere length in a bud32D strain harboring the
CDC13-EST2 plasmid following the reintroduction of a pBUD32 or control plasmid.
(B) Quantitation of telomere lengths from the strains shown in (A).
(C) TRF analysis of est1D bud32D double-mutant cells expressing the CDC13-EST2 chimaeric gene. A wild-type strain expressing the Cdc13-Est2
fusion for 100 generations was deleted for EST1 (lanes 3 and 4), BUD32 (lanes 5 and 6), or for both EST1 and BUD32 (lanes 7–10). Strains underwent
an additional 75 generations at the time of harvest.
(D) In vitro telomerase activity is not affected by BUD32 deletion. Partially DEAE-purified protein fractions were prepared from wild-type (DDY1240),
bud32D (DDY1241), and est2D (DDY1242) strains. Telomerase activity was detected as an RNase-sensitive activity in primer extension assays per-
formed as described in Cohn and Blackburn (1995). The absence of extension products in extracts prepared from est2D cells further indicates that the
activity observed is due to telomerase. In vitro reconstituted human telomerase was used as a positive control.Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc. 1165
of telomere regulation by the KEOPS complex are the fruit
of a single biochemical activity remains to be specifically
addressed. However, we note that a kinase-dead allele
of BUD32 (bud32-K52A) displays both telomere shorten-
ing and cdc13-1 suppression, supporting the idea that
both phenotypes are controlled by a single biochemical
activity borne by the KEOPS complex.
In order to gain further insight into the mechanism by
which the KEOPS complex affect telomeres, we sought
to determine whether Bud32 is enriched at telomeres via
chromatin immunoprecipitation (Figure S7). Although our
results are consistent with Bud32 being slightly enriched
at telomeres, further work will be required to determine
whether this localization is important for telomere regula-
tion. In fact, as the KEOPS complex contains one or
more enzymatic activity, it is plausible that a fleeting inter-
action between the KEOPS complex and telomeres is suf-
ficient to have the profound impact on telomere homeo-
stasis documented here.
From our observations we propose that the KEOPS
complex regulates access to the chromosome end (Fig-
ure S8). Although other models can explain our data, we
favor this model as it is by far the simplest way to account
for the observed functions of KEOPS components in the
regulation of both telomere-length homeostasis and cap-
ping. In this model, an ‘‘open’’ telomere conformation is
promoted by the KEOPS complex. This open state would
allow both telomerase access and would promote exonu-
clease degradation of the chromosome end following telo-
mere uncapping.
Importantly, since the targeted delivery of telomerase to
the chromosome end does not cause significant telomere
lengthening in bud32D cells (Figure 7A), we believe that
the short telomere defect observed in KEOPS mutants is
not, in large part, related to a failure in telomerase recruit-
ment. Rather, the accessibility of the 30 end of the chromo-
some to Est2 may be limited in cells lacking BUD32. Inter-
estingly, data from Evans and Lundblad (1999) suggest
that Est1, in addition to its proposed role as a telome-
rase-targeting factor, possesses a secondary function re-
quired for telomere elongation; namely to promote acces-
sibility to the chromosome 30 end. We are tempted to
speculate that Bud32, by virtue of its demonstrated pro-
tein kinase activity, may regulate this Est1 function via pro-
tein phosphorylation. Remarkably, regulation of access to
the chromosome 30 end can be easily imagined if a struc-
ture similar to the t loop exists in yeast (Griffith et al., 1999).
Indeed, such a structure would represent an attractive site
for KEOPS action since t loops have been shown to link
telomere-end protection and telomere elongation to the
regulation of chromosome-end accessibility (de Lange,
2005). Finally, an alternative model for our data can be
elaborated in light of the proposed function of Est1 as an
activator of telomerase (Taggart et al., 2002). In this
case, the KEOPS complex could act as a regulator or ef-
fector of this Est1 activity. However, despite the fact that
such a role would easily explain the telomere length and
healing phenotypes of bud32 or cgi121D mutants, it is1166 Cell 124, 1155–1168, March 24, 2006 ª2006 Elsevier Inc.less clear how the catalytic activity of telomerase can reg-
ulate telomere capping. Nevertheless, such a role for the
telomerase complex has been previously proposed or im-
plied (Chan and Blackburn, 2003; Teo and Jackson, 2001)
and may be supported by our finding that deletion of PIF1,
a gene encoding a catalytic inhibitor of telomerase (Boule
et al., 2005), potently suppress cdc13-1 (Figure 1). There-
fore, this possibility cannot be ruled out until addressed
experimentally.
Conservation of KEOPS Complex Components
in Metazoans
In addition to Bud32 (PRPK) and Cgi121(hCGI-121), which
are both well conserved in human cells, Kae1 (hOSGEP),
but not Gon7, are also conserved across eukaryotes
(Miyoshi et al., 2003; Seki et al., 2002). This sequence con-
servation and the previously described PRPK/hCGI-121
interaction suggests that the architecture of the KEOPS
complex may be evolutionarily conserved. Whether the
KEOPS complex plays a role in human telomere-length
homeostasis, capping regulation, or t loop function will
form the core of our future investigations.
EXPERIMENTAL PROCEDURES
A detailed version of the Experimental Procedures has been included
in the Supplemental Data in addition to two Supplemental Tables and
eight Supplemental Figures.
Yeast Manipulation
All strains are derivatives of W303 or S288C as indicated in Table S2.
Yeast strains were constructed using standard genetic procedures
either by genetic crosses or by homologous recombination. Cells were
grown in supplemented minimal medium or in rich (XY) medium as in-
dicated, to which glucose, raffinose, or raffinose plus galactose in vari-
able proportions was added to a final concentration of 2%.
Synthetic Genetic Array
An S288C strain containing the cdc13-1 mutation flanked by URA3
and LEU2 markers (DLY2304) was mated into a set of 4800 haploid
gene-deletion mutants and sporulated, germinated, and passaged es-
sentially as previously described (Tong et al., 2001). Haploid mutants
containing gene-deletion mutants and the cdc13-1 point mutant
were grown overnight at 20ºC in selective media in 96-well plates,
and dilution series of each strain were spotted at permissive (23ºC),
semipermissive (27.5–28ºC), and nonpermissive (37ºC) temperatures
on rich media. Strains showing consistent growth at 23ºC and
27.5ºC but not 37ºC in both repetitions of the screen were prioritized
for further study.
Quantitative Amplification of Single-Stranded DNA (QAOS)
DNA from the indicated strain was prepared from frozen cell pellets,
and real-time PCR ssDNA measurements and the primers/probes
used were as previously described by Booth et al. (2001).
Telomere-Healing Assays
Telomere-healing/GCR assays were done essentially as described in
Kanellis et al. (2003) except that strains were streaked on synthetic me-
dia lacking uracil prior to inoculation of single colonies in 15 or 30 ml
cultures. For telomere-healing assays following and HO endonucle-
ase-induced DSB, strains were inoculated in SC-TRP-URA media con-
taining 2% raffinose and grown to a concentration of 1–5106 cells/ml.
Galactose was added to a final concentration of 3% for 3.5 hr and then
plated onto rich media. After 1–2 days, cells were replica plated onto
a-aminoadipate plates lacking adenine to select for telomere-healing
events (Bianchi et al., 2004).
Telomerase Assays
Yeast extract preparations, telomerase crude purification, and in vitro
telomerase assays were carried out essentially as described in Cohn
and Blackburn (1995).
Immunoprecipitations and Immunoblotting
Yeast protein extractions and immunoblotting were carried out in
native or denaturing conditions exactly as described in Kanellis et al.
(2003).
Supplemental Data
Supplemental Data include eight figures, two tables, and Supplemen-
tal Experimental Procedures and can be found with this article online
at http://www.cell.com/cgi/content/full/124/6/1155/DC1/.
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